Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × In Situ Hybridization, Fluorescence × Clear all

NCT01382706 2025-10-09

Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder

Phase 2 Terminated

15 enrolled 10 charts

Urinary Bladder Neoplasms